FDA 483 - T2 Biosystems, Inc. - September 24, 2021

An FDA inspection of T2 Biosystems, Inc. in Lexington, MA, a medical device manufacturer, revealed two significant observations. The firm failed to document corrective and preventive action activities as per its internal procedures. Additionally, T2 Biosystems, Inc. did not establish a required quality agreement with its sterilization contract manufacturer.